Brainstorm Cell Therapeutics Inc (FRA:GHDN)
€ 2.687999 2.469499 (1130.21%) Market Cap: 16.44 Mil Enterprise Value: 14.20 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100